Silence Therapeutics PLC
NASDAQ:SLN
Silence Therapeutics PLC
Interest Income Expense
Silence Therapeutics PLC
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Silence Therapeutics PLC
NASDAQ:SLN
|
Interest Income Expense
-£136k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Interest Income Expense
$570k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Interest Income Expense
-$29m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Interest Income Expense
$13.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
125%
|
CAGR 10-Years
N/A
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Interest Income Expense
-£344k
|
CAGR 3-Years
21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Genus PLC
LSE:GNS
|
Interest Income Expense
-£10.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-102%
|
CAGR 10-Years
-20%
|
See Also
What is Silence Therapeutics PLC's Interest Income Expense?
Interest Income Expense
-136k
GBP
Based on the financial report for Dec 31, 2019, Silence Therapeutics PLC's Interest Income Expense amounts to -136k GBP.